124 related articles for article (PubMed ID: 29380911)
1. Upregulation of Klotho potentially inhibits pulmonary vascular remodeling by blocking the activation of the Wnt signaling pathway in rats with PM2.5-induced pulmonary arterial hypertension.
Cong LH; Du SY; Wu YN; Liu Y; Li T; Wang H; Li G; Duan J
J Cell Biochem; 2018 Jul; 119(7):5581-5597. PubMed ID: 29380911
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibitor LF3 restrains the development of pulmonary hypertension through the Wnt/β-catenin pathway.
Lei Y; Yang Q; Nie Y; Wan J; Deng M
Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1277-1289. PubMed ID: 34410330
[TBL] [Abstract][Full Text] [Related]
3. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
Li YX; Run L; Shi T; Zhang YJ
Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
[TBL] [Abstract][Full Text] [Related]
4. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.
Cai Z; Li J; Zhuang Q; Zhang X; Yuan A; Shen L; Kang K; Qu B; Tang Y; Pu J; Gou D; Shen J
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29700287
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway.
Liu YY; Zhang WY; Wang CG; Huang JA; Jiang JH; Zeng DX
Microvasc Res; 2020 Jul; 130():103988. PubMed ID: 32057731
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
Yan D; Li G; Zhang Y; Liu Y
Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
[No Abstract] [Full Text] [Related]
10. Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery-jugular vein shunt pulmonary hypertension rat model.
Ma X; Yao J; Yue Y; Du S; Qin H; Hou J; Wu Z
Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):206-211. PubMed ID: 28475806
[TBL] [Abstract][Full Text] [Related]
11. Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70.
Chen F; Wang H; Yan J; Lai J; Cai S; Yuan L; Zheng S
Biomed Pharmacother; 2018 May; 101():123-128. PubMed ID: 29482057
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
14. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
15. α-Solanine reverses pulmonary vascular remodeling and vascular angiogenesis in experimental pulmonary artery hypertension.
Nie X; Dai Y; Tan J; Chen Y; Qin G; Mao W; Zou J; Chang Y; Wang Q; Chen J
J Hypertens; 2017 Dec; 35(12):2419-2435. PubMed ID: 28704260
[TBL] [Abstract][Full Text] [Related]
16. Sulfur dioxide attenuates hypoxia-induced pulmonary arteriolar remodeling via Dkk1/Wnt signaling pathway.
Luo L; Hong X; Diao B; Chen S; Hei M
Biomed Pharmacother; 2018 Oct; 106():692-698. PubMed ID: 29990860
[TBL] [Abstract][Full Text] [Related]
17. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
Zhang M; Chang Z; Zhang P; Jing Z; Yan L; Feng J; Hu Z; Xu Q; Zhou W; Ma P; Hao Y; Zhou R
Chem Biol Interact; 2019 Sep; 311():108749. PubMed ID: 31325423
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B
Li S; Zhai C; Shi W; Feng W; Xie X; Pan Y; Wang J; Yan X; Chai L; Wang Q; Zhang Q; Liu P; Li M
Eur J Pharmacol; 2020 Jan; 867():172823. PubMed ID: 31770525
[TBL] [Abstract][Full Text] [Related]
20. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]